BELLUS Health Inc.

Corporate Profile

BELLUS Health is a global health company focused on the development and commercialization of products to provide innovative health solutions to address critical unmet medical needs. BELLUS Health is engaged in pharmaceutical and nutraceutical activities. The first of these activities targets disorders for which there are currently no known cures and limited therapies. It includes the development of investigational product candidates for the treatment of Amyloid A Amyloidosis, Type II diabetes and certain features of metabolic syndrome, and Alzheimer’s disease.

In respect of nutraceuticals, the Corporation is taking steps, through its wholly owned subsidiary, OVOS Natural Health Inc., to research, develop and commercialize branded nutraceuticals that target condition-specific needs of consumers, with a focus primarily on memory and cognition.

BELLUS Health (International) Limited, a wholly owned subsidiary of BELLUS Health Inc., is located just outside Lausanne, in Ecublens, Switzerland, and is the international headquarters for the BELLUS Health group of companies and the owner of the group’s international therapeutic rights. It was established to undertake the international commercialization of the group’s products, including licensing and partnering activities, supply chain management and sales, and the clinical, regulatory and marketing functions required to develop the group’s products internationally.

Quick Facts

History
BELLUS Health Inc. (formerly Neurochem Inc.) was incorporated in 1993 in association with PARTEQ Research and Development Innovations, the technology transfer office of Queen’s University, Kingston, Ontario to develop and commercialize small organic molecules, the basis of BELLUS Health Inc.’s unique technology, discovered by lead researchers at Queen’s University.

Stock listing
Toronto Stock Exchange (TSX)
Symbol: BLU
NASDAQ National Market
Symbol: BLUS

Head Office (Canada)
BELLUS Health Inc.
275 Armand-Frappier Blvd.
Laval, Quebec H7V 4A7
T 450 680 4500
T 877 680 4500
F 450 680 4501
BellusHealth.com

Main technologies
BELLUS Health Inc. has developed significant capabilities in the areas of amyloidosis, neurological clinical development and research expertise and technology, including blood brain barrier, neurotoxicity, kidney function and features of metabolic syndrome. The Company continues to be a world leader in two of its founding disciplines - amyloid biology and biochemistry – both in vitro and in vivo.